797-58-0 (双乙基诺龙,18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)-)

双乙基诺龙(797-58-0)名称与标识符

名称

中文别名:
双乙基诺龙;Norbolethone;诺勃酮;
英文别名:
18,19-Dinorpregn-4-en-3-one,13-ethyl-17-hydroxy-, (17a)-;Norbolethone;α-Norbolethone;Aids125925;Aids-125925;Norbalethone;Gon-4-en-3-one,17.alpha.-diethyl-17-hydroxy-;D05204;O60979L83F;797-58-0;dl-13,17a-Diethyl-17-hydroxygon-4-en-3-one;NORBOLETHONE [MI];WLN: L E5 B666 OV MUTJ E2 FQ F2;Norbolhetone;(+/-)-17a-Ethyl-18-homo-19-nortestosterone;Norboletonum [INN-Latin];(+/-)-13-ethyl-17-hydroxy-18,19-Dinor-17a-pregn-4-en-3-one;Genabol;AKOS030253215;NS00067955;(17.ALPHA.)-13-ETHYL-17-HYDROXY-18,19-DINORPREGN-4-EN-3-ONE;NSC89791;1235-15-0;Norboletone;13,17.ALPHA.-DIETHYL-17-HYDROXYGON-4-EN-3-ONE;HY-U00108;13.BETA.,17.ALPHA.-DIETHYL-17.BETA.-HYDROXYGON-4-EN-3-ONE;Norboletona [INN-Spanish];18,19-DINORPREGN-4-EN-3-ONE, 13-ETHYL-17-HYDROXY-, (17.ALPHA.)-, (+/-)-;Norboletone, (+)-;(1S,2R,10R,11S,14S,15S)-14,15-diethyl-14-hydroxytetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one;CHEMBL2105134;Norbolethone (1.0mg/ml in Acetonitrile);(+/-)-13,17a-Diethyl-17b-hydroxygon-4-en-3-one;MLS002694957;Norbolethone D-form [MI];alpha-Norbolethone;18, 13-ethyl-17-hydroxy-;CS-7144;18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-, (+-)-;18,19-Dinor-17alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-;(17a)-(+/-)-13-ethyl-17-hydroxy-18,19-Dinorpregn-4-en-3-one;dl-17b-Hydroxy-13b,17a-diethylgon-4-en-3-one;18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17.alpha.)-;18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17-alpha)-;FTBJKONNNSKOLX-XUDSTZEESA-N;UNII-U3BZU2241A;Norboletonum;Norbolethone (USAN);13-Ethyl-17-hydroxy-18,19-dinor-17-alpha-pregn-4-en-3-one;DL-13,17a-Diethyl-17b-hydroxygon-4-en-3-one;SCHEMBL548124;(+/-)-13b,17a-Diethyl-17b-hydroxygon-4-en-3-one;18,19-Dinorpregn-4-en-3-one, 13-ethyl-17-hydroxy-, (17alpha)-, (+-)-;Wy 3475;18,19-Dinor-17.alpha.-pregn-4-en-3-one, 13-ethyl-17-hydroxy-;D-Norbolethone;(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-3-one;Norbolethone [USAN];U3BZU2241A;(.+-.)-13-Ethyl-17-hydroxy-18,19-dinor-17.alpha.-pregn-4-en-3-one;DTXSID50154027;(+-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha -pregn-4-en-3-one;DL-Norbolethone;NSC-89791;18, 13-ethyl-17-hydroxy-, (17.alpha.)-;WY-3475;UNII-O60979L83F;13-ethyl-17-hydroxy-18,19-dinor-17-pregn-4-en-20-yn-3-one;18,19-Dinor-17-alpha-pregn-4-en-3-one, 13-ethyl-17-hydroxy-;13beta,17alpha-Diethyl-17beta-hydroxygon-4-en-3-one;Norboletona;NSC 89791;Q410981;NORBOLETONE [MART.];dl-13-beta,17-alpha-Diethyl-17-beta-hydroxygon-4-en-3-one;Norbolethone [USAN:INN];13-ethyl-17-hydroxy-18,19-dinor-17a-pregn-4-en-3-one;DTXSID801015371;Norboletone [INN];(8R,9S,10R,13S,14S,17S)-13,17-diethyl-17-hydroxy-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one;3-Ethyl-17-hydroxy-18,19-dinor-pregn-4-en-3-one;Norbolethone, (+)-;13-ETHYL-17-HYDROXY-18,19-DINOR-17.ALPHA.-PREGN-4-EN-3-ONE;

标识符

InChIKey:
FTBJKONNNSKOLX-XUDSTZEESA-N
Inchi:
1S/C21H32O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h13,16-19,23H,3-12H2,1-2H3/t16-,17+,18+,19-,20-,21-/m0/s1
SMILES:
O[C@@]1(CC)CC[C@H]2[C@@H]3CCC4=CC(CC[C@@H]4[C@H]3CC[C@@]21CC)=O

双乙基诺龙(797-58-0)物化性质

实验特性

  • LogP : 4.65940
  • PSA : 37.30000
  • 折射率 : 1.5344 (estimate)
  • 沸点 : 395.89°C (rough estimate)
  • 闪点 : 195.6ºC
  • 密度 : 1.0382 (rough estimate)

计算特性

  • 精确分子量 : 316.24000
  • 氢键供体数量 : 1
  • 氢键受体数量 : 2
  • 可旋转化学键数量 : 2
  • 同位素质量 : 316.24
  • 重原子数量 : 23
  • 复杂度 : 536
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 6
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 3.8
  • 拓扑分子极性表面积 : 37.3A^2

双乙基诺龙(797-58-0)推荐厂家 更多厂家(2)

公司名称手机号/电话联系人QQ微信询单
上海瀚思化工有限公司 18939883912
021-34536277
顾经理 3003949364
询单
上海吉至生化科技有限公司 18117592386
021-57481218
吉至试剂 3007522982
询单